Niederle B - Search Results

1

Distinction between sporadic and hereditary medullary thyroid carcinoma (MTC) by mutation analysis of the RET proto-oncogene. "Study Group Multiple Endocrine Neoplasia Austria (SMENA)".

Fink M, Weinhüsel A, Niederle B, Haas OA. Fink M, et al. Among authors: niederle b. Int J Cancer. 1996 Aug 22;69(4):312-6. doi: 10.1002/(SICI)1097-0215(19960822)69:4<312::AID-IJC13>3.0.CO;2-7. Int J Cancer. 1996. PMID: 8797874

2

Cytogenetic and CGH studies of four neuroendocrine tumors and tumor-derived cell lines of a patient with multiple endocrine neoplasia type 1.

Sigl E, Behmel A, Henn T, Wirnsberger G, Weinhausl A, Kaserer K, Niederle B, Pfragner R. Sigl E, et al. Among authors: niederle b. Int J Oncol. 1999 Jul;15(1):41-51. doi: 10.3892/ijo.15.1.41. Int J Oncol. 1999. PMID: 10375592

3

First continuous human pheochromocytoma cell line: KNA. Biological, cytogenetic and molecular characterization of KNA cells.

Pfragner R, Behmel A, Smith DP, Ponder BA, Wirnsberger G, Rinner I, Porta S, Henn T, Niederle B. Pfragner R, et al. Among authors: niederle b. J Neurocytol. 1998 Mar;27(3):175-86. doi: 10.1023/a:1006959625068. J Neurocytol. 1998. PMID: 10640177

4

Novel SDHD germ-line mutations in pheochromocytoma patients.

Neumayer C, Moritz A, Asari R, Weinhäusel A, Hölzenbein T, Kretschmer G, Niederle B, Haas OA. Neumayer C, et al. Among authors: niederle b. Eur J Clin Invest. 2007 Jul;37(7):544-51. doi: 10.1111/j.1365-2362.2007.01822.x. Eur J Clin Invest. 2007. PMID: 17576205

5

Primary hyperparathyroidism in Austria: results of an 8-year prospective study.

Niederle B, Stamm L, Längle F, Schubert E, Woloszczuk W, Prager R. Niederle B, et al. World J Surg. 1992 Jul-Aug;16(4):777-82; discussion 782-3. doi: 10.1007/BF02067385. World J Surg. 1992. PMID: 1413848

6

Biologic and cytogenetic characterization of three human medullary thyroid carcinomas in culture.

Pfragner R, Wirnsberger G, Behmel A, Niederle B, Längle F, Roka R, Mandl A, Pürstner P, Auner J, Tatzber F. Pfragner R, et al. Among authors: niederle b. Henry Ford Hosp Med J. 1992;40(3-4):299-302. Henry Ford Hosp Med J. 1992. PMID: 1483877

7

Primary hyperparathyroidism as the leading symptom in a patient with a Y791F RET mutation.

Vierhapper H, Rondot S, Schulze E, Wagner L, Hanslik S, Niederle B, Bieglmayer C, Kaserer K, Baumgartner-Parzer S. Vierhapper H, et al. Among authors: niederle b. Thyroid. 2005 Nov;15(11):1303-8. doi: 10.1089/thy.2005.15.1303. Thyroid. 2005. PMID: 16356097

8

Is medullary thyroid cancer predictable? A prospective study of 86 patients with abnormal pentagastrin tests.

Scheuba C, Kaserer K, Weinhäusl A, Pandev R, Kaider A, Passler C, Prager G, Vierhapper H, Haas OA, Niederle B. Scheuba C, et al. Among authors: niederle b. Surgery. 1999 Dec;126(6):1089-95; discussion 1096. doi: 10.1067/msy.2099.102268. Surgery. 1999. PMID: 10598192

9

CD15 (LeuM1) immunoreactivity: prognostic factor for sporadic and hereditary medullary thyroid cancer? Study Group on Multiple Endocrine Neoplasia of Austria.

Längle F, Soliman T, Neuhold N, Widhalm G, Niederle B, Roka S, Kaserer K, Blauensteiner W, Dam K, Clodi M, et al. Längle F, et al. Among authors: niederle b. World J Surg. 1994 Jul-Aug;18(4):583-7. doi: 10.1007/BF00353771. World J Surg. 1994. PMID: 7725748 Clinical Trial.

10

Evaluation of glucose tolerance, insulin secretion, and insulin action in patients with primary hyperparathyroidism before and after surgery.

Prager R, Schernthaner G, Niederle B, Roka R. Prager R, et al. Among authors: niederle b. Calcif Tissue Int. 1990 Jan;46(1):1-4. doi: 10.1007/BF02555816. Calcif Tissue Int. 1990. PMID: 2104769

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results